Does molecular targeted therapy change the treatment for lung cancer?

Yoichi Nakanishi

Does molecular targeted therapy change the treatment for lung cancer?

Yoichi Nakanishi

Department of Respirology

Research output: Contribution to journal › Review article

Original language	English
Pages (from-to)	205-209
Number of pages	5
Journal	Fukuoka igaku zasshi = Hukuoka acta medica
Volume	95
Issue number	9
Publication status	Published - Sep 2004

Fingerprint

Pathologic Neovascularization

Molecular Targeted Therapy

Quinazolines

erbB-1 Genes

Tumor Suppressor Protein p53

Synthetic Vaccines

Vascular Endothelial Growth Factor Receptor

Genetic Therapy

Antineoplastic Agents

Lung Neoplasms

Cell Cycle

Therapeutics

All Science Journal Classification (ASJC) codes

Medicine(all)

Cite this

Nakanishi, Y. (2004). Does molecular targeted therapy change the treatment for lung cancer? Fukuoka igaku zasshi = Hukuoka acta medica, 95(9), 205-209.

Does molecular targeted therapy change the treatment for lung cancer? / Nakanishi, Yoichi.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 95, No. 9, 09.2004, p. 205-209.

Research output: Contribution to journal › Review article

Nakanishi, Y 2004, 'Does molecular targeted therapy change the treatment for lung cancer?', Fukuoka igaku zasshi = Hukuoka acta medica, vol. 95, no. 9, pp. 205-209.

Nakanishi Y. Does molecular targeted therapy change the treatment for lung cancer? Fukuoka igaku zasshi = Hukuoka acta medica. 2004 Sep;95(9):205-209.

Nakanishi, Yoichi. / Does molecular targeted therapy change the treatment for lung cancer?. In: Fukuoka igaku zasshi = Hukuoka acta medica. 2004 ; Vol. 95, No. 9. pp. 205-209.

@article{a203e75cbf3e4cf0bebf7654200c1f2f,

title = "Does molecular targeted therapy change the treatment for lung cancer?",

author = "Yoichi Nakanishi",

year = "2004",

month = "9",

language = "English",

volume = "95",

pages = "205--209",

journal = "Fukuoka Acta Medica",

issn = "0016-254X",